XOLAIR subst sèche 150 mg c solv flac
7680571780032
CH-57178
R03DX05
03.04.5.
Reimbursement limitations:
XOLAIR3
Asthme allergique sévère résistant à d'autres thérapies. Prescription par un spécialiste (pneumologue, allergologue). La prescription …
1 / 2
google
Details
- Product number
- 5717802
- CPT
- -
- Packaging group
- 1
- Unit
- Ampulle(n)
- Composition
- Praeparatio cryodesiccata: omalizumabum 150 mg, histidini hydrochloridum monohydricum, histidinum, saccharum, polysorbatum 20, pro vitro. Solvens: aqua ad iniectabile.
Articles (1)
Xolair 150 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
- | Substance | HNIDK |
|
PRC
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 417.05
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2006
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 57178
- Drug name
- Xolair, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
- Galenic form
- PULMJ
- ATC Code
- R03DX05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/09/2006
- Authorization expiration date
- 31/12/9999
- IT number
- 03.04.5.
- Domain
- Human medicine
Packaging details
- Description (FR)
- XOLAIR subst sèche 150 mg c solv flac
- Description (DE)
- XOLAIR Trockensub 150 mg c Solv Durchstf
- Market launch
- 18/09/2006
- Narcotic (BTM)
- No